Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapoxetine Flexible Dose in Premature Ejaculation
NCT01063881Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dapoxetine in premature ejaculation (PE), sponsored by Janssen Pharmaceutical. Started May 2010; status: completed.
02
Drugs
dapoxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01063881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063881.